早泄手术喀什甲级医院喀什切包皮过长环切价格,喀什早孕试纸多久测,喀什男人割包皮一共多少钱,喀什包皮环切专科医院,喀什去哪家医院治妇科,喀什阴道紧缩修护医院,喀什包皮一定要切掉吗

BEIJING, Jan. 27 (Xinhua) -- A senior Chinese official has called on the country's religious figures to make more contributions to economic and social development by innovating and improving social services.Jia Qinglin, a member of the Standing Committee of the Political Bureau of the Communist Party of China (CPC) Central Committee, made the remark at a meeting Thursday while offering lunar New Year's greetings to religious circles on behalf of the CPC Central Committee.Jia Qinglin (front, R), chairman of the National Committee of the Chinese People's Political Consultative Conference (CPPCC), and a member of the Standing Committee of the Political Bureau of the Communist Party of China (CPC) Central Committee, shakes hands with one of the leaders of the religious groups during an informal discussion sponsored by CPPCC in Beijing, capital of China, Jan. 27, 2011, to celebrate the upcoming Spring Festival.Jia said Chinese citizens' freedom in religious belief was fully protected, and the religious circles had provided excellent services for people from around the world during the Shanghai World Expo and Guangzhou Asian Games last year.The official asked the religious circles to pay more attention to helping grassroots religious groups and believers and improving their management.

STOCKHOLM, Feb. 20 (Xinhua) -- The exhibition of the Chinese Terra-cotta Army here was an enormous success, project organizer Sanne Houby-Nielsen said Sunday.About 320 objects, including terra-cotta warriors from the ancient Chinese Qin Dynasty and other terra-cotta figures from Han Dynasty, were exhibited at the Far Eastern Antiquities Museum during the event, which ended Sunday.Houby-Nielsen, who is director of the museum and also director-general of the country's National Museums of World Culture, told Xinhua in an exclusive interview that the total number of visitors was around 350,000, more than double the expected turnout.This was the highest number of visitors the museum has ever experienced in its history since it was established in the 1940s, said Houby-Nielsen, adding that the exhibition was originally scheduled to end on Jan. 16, but "a great pressure from the audiences" prompted the museum to extend it till Sunday."It is an exhibition which won the most audience for many years in Sweden. We feel particularly happy because it was a very good display of the story of the first emperor and the early Han Dynasty," she said."We felt such a huge interest that we have to prolong it. So we were very grateful that it was possible to prolong the exhibition," she added.The exhibition was declared open by Swedish King Carl XVI Gustaf in August. Many of the ancient Chinese artifacts have never been exhibited outside China.Swedish Sinologist Cecelia Lindqvist commented that the event helped people understand the current China by looking at the history of China presented in the exhibition.

WASHINGTON, April 25 (Xinhua) -- A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan Comprehensive Cancer Center finds.Working in cell lines from colorectal cancer patients, researchers found that the class of drugs called PARP inhibitors worked against tumors with mutations in the MRE11 gene.About 15 percent of all colorectal cancers have what's called microsatellite instability, a type of error in the DNA. About 82 percent of those tumors have the MRE11 gene mutation."This is a potential broader application for PARP inhibitors, beyond breast and ovarian cancer. This is a class of drug that's already shown safety in early clinical trials and now might benefit some colorectal cancer patients as well," says lead study author Eduardo Vilar-Sanchez, a hematology/oncology fellow at the university, in a statement.The study, which was published Monday in Cancer Research, also found that PARP inhibitors are even more effective when both copies of MRE11 were mutated. Each person carries two copies of each gene, which means mutations can occur in either one or both copies. The researchers suggest that PARP inhibitors could be targeted specifically to colorectal cancer patients who have two copies of the mutated gene.Researchers are planning a phase I clinical trial to look at using PARP inhibitors in colorectal cancer patients with two mutated copies of MRE11. Future trials are being considered using PARP inhibitors to prevent colorectal cancer and other cancers in people with Lynch syndrome whose tumors have this mutation.Microsatellite instability is also seen in prostate cancer and endometrial cancer, suggesting potential for PARP inhibitors to play a role in additional types of cancer as well, Vilar-Sanchez says, adding that more research is needed in these areas.